Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Hurst

Showing results (21-30 of 341) with videos related to

Pageof 35
Sort By:
Archivos De Bronconeumologia|December 8, 2022
Optimal Treatment of the Symptomatic Smoker: Make a Diagnosis Not Empiric TreatmentMarc Miravitlles, John R Hurst
The European Respiratory Journal|February 16, 2023
ERJ advances: state of the art in definitions and diagnosis of COPDSachin Ananth, John R Hurst
The European Respiratory Journal|May 3, 2014
How to assess the severity of bronchiectasisAarash D Saleh, John R Hurst
Clinics in Chest Medicine|August 28, 2007
The biology of a chronic obstructive pulmonary disease exacerbationJohn R Hurst, Jadwiga A Wedzicha
The European Respiratory Journal|September 25, 2025
Pulmonary hypertension in COPD exacerbation: a transient storm with long-term consequences?Omer Faruk Uysal, John R Hurst
Immunology and Allergy Clinics of North America|January 23, 2013
COPD exacerbations: causes, prevention, and treatmentAlex J Mackay, John R Hurst
Thorax|January 14, 2021
COVID-19 and 'basal' exacerbation frequency in COPDDaryl O Cheng, John R Hurst
Thorax|November 6, 2016
Dyspnoea perception and susceptibility to exacerbation in COPDHeidi A Ridsdale, John R Hurst
The Medical Clinics of North America|July 17, 2012
COPD exacerbations: causes, prevention, and treatmentAlex J Mackay, John R Hurst
The Lancet. Respiratory Medicine|March 4, 2024
MACE in COPD: addressing cardiopulmonary riskJohn R Hurst, Chris P Gale,
Pageof 35

Showing results (21-30 of 341) with videos related to

Sort By:
Pageof 35
Archivos De Bronconeumologia|December 8, 2022
Optimal Treatment of the Symptomatic Smoker: Make a Diagnosis Not Empiric TreatmentMarc Miravitlles, John R Hurst
The European Respiratory Journal|February 16, 2023
ERJ advances: state of the art in definitions and diagnosis of COPDSachin Ananth, John R Hurst
The European Respiratory Journal|May 3, 2014
How to assess the severity of bronchiectasisAarash D Saleh, John R Hurst
Clinics in Chest Medicine|August 28, 2007
The biology of a chronic obstructive pulmonary disease exacerbationJohn R Hurst, Jadwiga A Wedzicha
The European Respiratory Journal|September 25, 2025
Pulmonary hypertension in COPD exacerbation: a transient storm with long-term consequences?Omer Faruk Uysal, John R Hurst
Immunology and Allergy Clinics of North America|January 23, 2013
COPD exacerbations: causes, prevention, and treatmentAlex J Mackay, John R Hurst
Thorax|January 14, 2021
COVID-19 and 'basal' exacerbation frequency in COPDDaryl O Cheng, John R Hurst
Thorax|November 6, 2016
Dyspnoea perception and susceptibility to exacerbation in COPDHeidi A Ridsdale, John R Hurst
The Medical Clinics of North America|July 17, 2012
COPD exacerbations: causes, prevention, and treatmentAlex J Mackay, John R Hurst
The Lancet. Respiratory Medicine|March 4, 2024
MACE in COPD: addressing cardiopulmonary riskJohn R Hurst, Chris P Gale,
Pageof 35